169 related articles for article (PubMed ID: 10945900)
1. Use of a novel marker, calponin, for myoepithelial cells in fine-needle aspirates of papillary breast lesions.
Mosunjac MB; Lewis MM; Lawson D; Cohen C
Diagn Cytopathol; 2000 Sep; 23(3):151-5. PubMed ID: 10945900
[TBL] [Abstract][Full Text] [Related]
2. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas.
Hill CB; Yeh IT
Am J Clin Pathol; 2005 Jan; 123(1):36-44. PubMed ID: 15762278
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical staining of papillary breast lesions.
Troxell ML; Masek M; Sibley RK
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):145-53. PubMed ID: 17525625
[TBL] [Abstract][Full Text] [Related]
4. Distribution of calponin and smooth muscle myosin heavy chain in fine-needle aspiration biopsies of the breast.
Dabbs DJ; Gown AM
Diagn Cytopathol; 1999 Apr; 20(4):203-7. PubMed ID: 10204102
[TBL] [Abstract][Full Text] [Related]
5. A Comparative Study of Immunohistochemical Myoepithelial Cell Markers in Cutaneous Benign Cystic Apocrine Lesions.
Wood A; Houghton SL; Biswas A
Am J Dermatopathol; 2016 Jul; 38(7):475-83. PubMed ID: 26630681
[TBL] [Abstract][Full Text] [Related]
6. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW
J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
Werling RW; Hwang H; Yaziji H; Gown AM
Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
[TBL] [Abstract][Full Text] [Related]
8. Use of p63 and CD10 in the differential diagnosis of papillary neoplasms of the breast.
de Moraes Schenka NG; Schenka AA; de Souza Queiroz L; de Almeida Matsura M; Vassallo J; Alvarenga M
Breast J; 2008; 14(1):68-75. PubMed ID: 18086274
[TBL] [Abstract][Full Text] [Related]
9. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.
Collins LC; Carlo VP; Hwang H; Barry TS; Gown AM; Schnitt SJ
Am J Surg Pathol; 2006 Aug; 30(8):1002-7. PubMed ID: 16861972
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of benign and malignant papillary lesions of the breast.
Papotti M; Eusebi V; Gugliotta P; Bussolati G
Am J Surg Pathol; 1983 Jul; 7(5):451-61. PubMed ID: 6351647
[TBL] [Abstract][Full Text] [Related]
11. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
12. Clinical and cytologic features of papillary neoplasms of the breast.
Choi YD; Gong GY; Kim MJ; Lee JS; Nam JH; Juhng SW; Choi C
Acta Cytol; 2006; 50(1):35-40. PubMed ID: 16514838
[TBL] [Abstract][Full Text] [Related]
13. CD44s as a surrogate marker for distinguishing intraductal papilloma from papillary carcinoma of the breast.
Saddik M; Lai R
J Clin Pathol; 1999 Nov; 52(11):862-4. PubMed ID: 10690183
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markers.
Rabban JT; Swain RS; Zaloudek CJ; Chase DR; Chen YY
Mod Pathol; 2006 Oct; 19(10):1351-7. PubMed ID: 16810311
[TBL] [Abstract][Full Text] [Related]
16. Myoepithelial cells in lobular carcinoma in situ: distribution and immunophenotype.
Wang Y; Jindal S; Martel M; Wu Y; Schedin P; Troxell M
Hum Pathol; 2016 Sep; 55():126-34. PubMed ID: 27195907
[TBL] [Abstract][Full Text] [Related]
17. D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion.
Ren S; Abuel-Haija M; Khurana JS; Zhang X
Int J Clin Exp Pathol; 2011 Jan; 4(2):175-82. PubMed ID: 21326813
[TBL] [Abstract][Full Text] [Related]
18. Benign versus malignant papillary neoplasms of the breast. Diagnostic clues in fine needle aspiration cytology.
Dawson AE; Mulford DK
Acta Cytol; 1994; 38(1):23-8. PubMed ID: 8291351
[TBL] [Abstract][Full Text] [Related]
19. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
Raju UB; Lee MW; Zarbo RJ; Crissman JD
Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
[TBL] [Abstract][Full Text] [Related]
20. Basal/myoepithelial cells in chronic sinusitis, respiratory epithelial adenomatoid hamartoma, inverted papilloma, and intestinal-type and nonintestinal-type sinonasal adenocarcinoma: an immunohistochemical study.
Ozolek JA; Barnes EL; Hunt JL
Arch Pathol Lab Med; 2007 Apr; 131(4):530-7. PubMed ID: 17425380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]